Lv3
372 积分 2024-06-12 加入
Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders
2小时前
待确认
ALK-positive lung cancer: a moving target
3个月前
已完结
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interaction
5个月前
已完结
Trends in the drug target landscape for autoimmune diseases
7个月前
已完结
Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease
9个月前
已完结
Artificial intelligence in drug development
9个月前
已完结
The clinical development of antibody–drug conjugates — lessons from leukaemia
9个月前
已完结
Discovery of Pyrrolopyrazine Carboxamide Derivatives as Potent and Selective FGFR2/3 Inhibitors that Overcome Mutant Resistance
9个月前
已完结
SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO
10个月前
已完结
Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein
10个月前
已完结
皖公网安备34019202002308
